OS Therapies Incorporated OSTX IPO will take place July, 31 on the NYSE exchange under the ticker OSTX.
The company is offering shares at an expected price of $4.00 per share with an insider lock-up period of 180 days ending on January 27, 2025.
See also: Benzinga IPO Calendar
About OS Therapies Incorporated
OS Therapies Incorporated is a clinical stage biopharmaceutical company. The Company focuses on the identification, development, and commercialization of treatments for osteosarcoma (OS) and other solid tumors.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
